Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates-Reference-Cited by-同舟云学术

Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates

Published:2017-11-10 Issue:1 Volume:17 Page:
ISSN:1472-6750
Container-title:BMC Biotechnology
language:en
Short-container-title:BMC Biotechnol

Author:

Kazaks Andris^ORCID,Lu I-Na,Farinelle Sophie,Ramirez Alex,Crescente Vincenzo,Blaha Benjamin,Ogonah Olotu,Mukhopadhyay Tarit,de Obanos Mapi Perez,Krimer Alejandro,Akopjana Inara,Bogans Janis,Ose Velta,Kirsteina Anna,Kazaka Tatjana,Stonehouse Nicola J.,Rowlands David J.,Muller Claude P.,Tars Kaspars,Rosenberg William M.

Funder

FP7 Health

Publisher

Springer Science and Business Media LLC

Subject

Biotechnology

Link

http://link.springer.com/content/pdf/10.1186/s12896-017-0396-8.pdf

Reference28 articles.

1. Kolpe A, Schepens B, Fiers W, Saelens X. M2-based influenza vaccines: recent advances and clinical potential. Expert Rev Vaccines. 2017;16(2):123–36.

2. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007;25(39–40):6852–62.

3. Berlanda Scorza F, Tsvetnitsky V, Donnelly JJ. Universal influenza vaccines: shifting to better vaccines. Vaccine. 2016;34(26):2926–33.